Skip to main content

Table 1 Basic characteristics of study participants at baseline

From: Comparison of Apolipoprotein B/A1 ratio, Framingham risk score and TC/HDL-c for predicting clinical outcomes in patients undergoing percutaneous coronary intervention

VariablesAll Patients (n = 2262)Follow-up Patients (n = 1639)With MACEs (n = 161)
Cardiovascular risk factors
 Age60.04 ± 10.7360.57 ± 10.8159.45 ± 10.65
 Gender, (n)men%1675 (74.05%)1201 (73.28%)113 (70.19%)*
 BMI24.37 ± 4.0824.34 ± 4.3023.76 ± 3.28
 Hypertension, n (%)1301 (57.51%)945 (57.66%)101 (62.73%)#
 hyperlipidemia, n (%)149 (6.59%)99 (6.04%)10 (6.21%)
 Diabetes, n (%)425 (18.79%)317 (19.34%)47 (29.19%)#
 Current/ex-smoker, n (%)1149 (50.79%)818 (49.91%)85 (52.79%)*
 Alcohol consumption (units per week), n (%)695 (30.73%)503 (30.69%)45 (27.95%)*
 Previous myocardial infarction, n (%)235 (10.39%)152 (9.27%)18 (11.18%)*
 Heart failure, n (%)35 (1.55%)25 (1.52%)5 (3.11%)*
 History of cerebrovascular disease, n (%)157 (6.94%)117 (7.13%)14 (8.69%)*
Biomarkers
 TC (mmol/L)4.33 ± 1.744.33 ± 1.664.31 ± 1.56
 HDL-C (mmol/L)1.07 ± 0.551.06 ± 0.471.09 ± 0.78
 LDL-C (mmol/L)2.50 ± 0.952.49 ± 0.932.52 ± 0.92*
 TG (mmol/L)1.89 ± 1.631.89 ± 1.561.84 ± 1.32
 ApoA1(g/L)1.18 ± 0.481.20 ± 0.551.15 ± 0.32
 ApoB(g/L)0.89 ± 0.490.90 ± 0.531.02 ± 0.79*
Blood pressure (mm Hg)
 Systolic140 ± 14.17140 ± 15.23141 ± 15.78
 Diastolic80 ± 13.1980 ± 13.2584 ± 12.86*
Coronary angiography
 1-vessel disease, n (%)683 (30.19%)497 (30.32)34 (21.12%)#
 2-vessel disease, n (%)712 (31.47%)515 (31.42)42 (26.08%)#
 3-vessel disease, n (%)867 (38.32%)626 (38.19)85 (52.80%)#
  1. All values are presented as mean ± SD, or number (%). BMI body mass index, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, TC total cholesterol, TG triglycerides, ApoA1 apolipoproteinA1, ApoB apolipoproteinB. *p < 0.05(With MACEs Vs. Follow-up Patients); #p < 0.01(With MACEs Vs. Follow-up Patients)